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Abstract
Background: Anthrax toxin is comprised of protective antigen (PA), lethal factor (LF), and edema factor (EF). These proteins
are individually nontoxic; however, when PA assembles with LF and EF, it produces lethal toxin and edema toxin,
respectively. Assembly occurs either on cell surfaces or in plasma. In each milieu, PA assembles into a mixture of heptameric
and octameric complexes that bind LF and EF. While octameric PA is the predominant form identified in plasma under
physiological conditions (pH 7.4, 37uC), heptameric PA is more prevalent on cell surfaces. The difference between these two
environments is that the anthrax toxin receptor (ANTXR) binds to PA on cell surfaces. It is known that the extracellular
ANTXR domain serves to stabilize toxin complexes containing the PA heptamer by preventing premature PA channel
formation—a process that inactivates the toxin. The role of ANTXR in PA oligomerization and in the stabilization of toxin
complexes containing octameric PA are not understood.
Methodology: Using a fluorescence assembly assay, we show that the extracellular ANTXR domain drives PA
oligomerization. Moreover, a dimeric ANTXR construct increases the extent of and accelerates the rate of PA assembly
relative to a monomeric ANTXR construct. Mass spectrometry analysis shows that heptameric and octameric PA oligomers
bind a full stoichiometric complement of ANTXR domains. Electron microscopy and circular dichroism studies reveal that
the two different PA oligomers are equally stabilized by ANTXR interactions.
Conclusions: We propose that PA oligomerization is driven by dimeric ANTXR complexes on cell surfaces. Through their
interaction with the ANTXR, toxin complexes containing heptameric and octameric PA oligomers are similarly stabilized.
Considering both the relative instability of the PA heptamer and extracellular assembly pathway identified in plasma, we
propose a means to regulate the development of toxin gradients around sites of infection during anthrax pathogenesis.
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Introduction
Anthrax toxin (Atx) [1] is a key virulence factor produced by
pathogenic strains of Bacillus anthracis. Atx consists of three
nontoxic protein components: protective antigen (PA) is an 83-
kDa, cell-binding component of Atx that ultimately forms an
oligomeric translocase channel, which delivers the two enzyme
components, lethal factor (LF) and edema factor (EF), into the
cytosol of a host cell [2,3,4]. LF is a 90-kDa, zinc-dependent
protease [5,6,7], which cleaves host-cell mitogen-activated
protein kinase kinases [5,6]. While PA and LF are individually
nontoxic, the combination of LF and PA creates lethal toxin
(LT), which can alter cellular physiology and cause death [8].
EF is a 89-kDa, Ca
2+/calmodulin-activated adenylyl cyclase
[9,10,11]. Analogously, PA and EF combine to form edema
toxin (ET), which induces tissue swelling and may also cause
death [8,12].
To achieve cytotoxicity, PA, LF, and EF must first self-assemble
into holotoxin complexes. There are two different types of
assembly pathways: (i) a cell-surface pathway and (ii) a plasma-
based/extracellular pathway. In the former mechanism, PA forms
complexes on the surface of host cells in a receptor-dependent
manner. PA first binds to one of two known Atx receptors
(ANTXR): ANTXR1 [13] and ANTXR2 [14]. The PA-ANTXR
interaction [15] is stable and dissociates with a half-life measured
in days [16]; the interaction involves domains 2 and 4 in PA, such
that the latter domain coordinates the receptor’ Ca
2+ or Mg
2+
metal ion adhesion site [15,16,17,18]. Receptor-bound PA is then
cleaved by a furin-type protease to make the proteolytically-
activated form, called nPA. After a 20-kDa portion of nPA (PA20)
dissociates, the remaining 63-kDa (PA63), receptor-bound portion
assembles into a mixture of ring-shaped heptameric (PA7)
[17,19,20] and octameric (PA8) [21,22] oligomers. The complexes
are endocytosed [23] and brought to an acidic compartment [24].
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e13888Under acidic pH conditions, the PA oligomers form translocase
channels [25,26], allowing the passage of LF and EF into the
cytosol.
In a second assembly mechanism, PA, LF, and EF form LT and
ET complexes in the blood. In vivo studies of anthrax infection
measured high concentrations of toxin components in the blood of
infected animals [2,3]. At the later stages of anthrax, PA and LF
concentrations reach up to 100 mg/mL and 20 mg/mL, respec-
tively [27]. Analysis of the circulating toxin components revealed
that the majority of detectable PA exists as the proteolytically-
processed PA63 form, which is either assembled or capable of
assembling with LF in a manner analogous to what is observed on
cell surfaces [27,28,29]. In vitro bovine-plasma assembly experi-
ments reveal that PA oligomers and LT complexes may form
efficiently from full-length PA and LF, where the resulting
oligomers contain mixtures of PA7 and PA8 complexes [21,22].
PA7 complexes have a strong propensity for aggregation under
physiological conditions (due to their premature conversion to the
channel state), suggesting that the toxin requires additional
stabilization mechanisms to remain efficacious during infection
[21,22,30]. Since PA8 complexes are more stable in plasma under
physiological conditions (pH 7.4, 37uC), it has been proposed [22]
that the soluble fraction of LT circulating in bloodstream of
infected animals [28] may contain an enriched population of the
PA8 oligomer.
While it is clear that PA8 functions as a stable complex in
plasma, it is unknown whether PA7 and PA8 complexes are
stabilized differentially on cell surfaces. When the PA heptamer
binds to its cellular receptor, ANTXR, the interaction inhibits
channel formation, significantly stabilizing PA complexes by ,2
pH units [15,17]. Previous studies have also shown that ANTXR2
dimerization leads to an increase in the formation of PA8 in vitro,
presumably by populating dimeric intermediates along the
assembly pathway [21]. Here we explore the role of the ANTXR
in the PA assembly pathway and determine the degree of
stabilization the receptor imparts on the two different PA
oligomers produced during assembly.
Results
PA oligomerization is accelerated in the presence of
ANTXR2 dimers
While ANTXR2 dimerization enhances the formation of PA8
[21], it is not known whether the rate and extent of PA
oligomerization are influenced by a dimeric ANTXR2 complex
(dsANTXR2). A previous study indicates that LF’s PA binding
domain (LFN, the first 263 residues of LF) can increase the rate of
PA oligomerization, while soluble monomeric ANTXR2 extracel-
lular domain (msANTXR2) did not appear to influence assembly
greatly [16]. To ask whether ANTXR2 dimerization affects the rate
of PA oligomerization, we produced a soluble extracellular
dsANTXR2 construct, which contains an amino-terminal fusion
of glutathione S-transferase (GST) and the extracellular domain of
ANTXR2. The GST domain forms tight homodimers [31] with an
equilibrium dissociation constant of less than 1 nM [32]. We
previously verified that this construct is fully homodimeric by mass
spectrometry [21]. Structurally, the amino-termini of adjacent
ANTXR2 extracellular domains in the crystal structure of the
PA7(ANTXR2)7 structure [17] are ,55 A ˚ apart (Fig. 1A). This
distance is similar to the distance between the carboxy-termini
(,44 A ˚) in the crystal structure of the GST dimer [31], and we infer
that the 6-amino acid linkers positioned between the GST domains
and the ANTXR2 domains can span this 11-A ˚ differential. Finally,
as our model in Figure 1A indicates, the amino terminus of the
ANTXR2 points away from the PA-ANTXR interface, and there
are no steric constraints, which would prevent the ANTXR2 dimer
from forming via the GST interaction either in a PA dimer or
higher-order PA7/PA8 oligomer complex. Thus this dimeric fusion
construct could in principle stabilize the formation of productive
dimeric PA intermediates during assembly.
Figure 1. ANTXR2 dimerization stimulates PA assembly. (A) A manually constructed model of dsANTXR2 bound to two adjacent PA63
subunits in a PA7 oligomer. The surface rendering is colored according to the legend on the right. The model is based upon the crystal structures of
GST (PDB 5GST[31]) and PA7(msANTXR2)7 (PDB 1TZN[17]). A flexible linker is shown in black that links the carboxy-terminus of GST to the amino-
terminus of msANTXR2. (B) FRET-probed PA-assembly kinetics at pH 7.4. A 1:1 mixture of nPA K563C*AF555 and nPA K563C*AF647 monomers (100 nM
total monomer) was either allowed to assemble on its own (black &) or mixed with 100 nM of the following assembly co-factors, dsANTXR2 (blue .),
msANTXR2 (green m), or LFN (redN), and allowed to assemble. To track the time course of PA assembly, the ratio of acceptor to donor fluorescence
(F668/F566) was measured every five minutes for one hour at room temperature. The resulting records are normalized to the largest signal obtained for
the dsANTXR co-assembly reaction. Solid lines are best-fit lines obtained using a second-order rate model (Eq. 1). The rate constants, k, are 0.19
(60.01) s
21 for dsANTXR2, 0.031 (60.003) s
21 for LFN, and 0.05 (60.03) s
21 for msANTXR2, and the amplitudes, A, are 21.12 (60.02) for dsANTXR2,
21.29 (60.04) for LFN, and 20.15 (60.02) for msANTXR2. Note due to the lack of an observable change in FRET signal, no kinetic parameters were
obtained for the assembly of nPA alone, and the data were fit to a straight line.
doi:10.1371/journal.pone.0013888.g001
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resonance energy transfer (FRET). AlexaFluor 555 and 647
reactive maleimides are conjugated to PA monomers via sulfhydryl
modification of the unique Cys residue introduced by the K563C
mutation, forming PA K563C*AF555 and PA K563C*AF647,
respectively. These residues are sufficiently close together in the
PA oligomer to allow FRET between adjacent monomers [16].
We monitor PA assembly using a 1:1 mixture of AF555-donor-and
AF647-acceptor-labeled nicked-PA (nPA) monomers (50 nM each)
and the ratio of the fluorescence emission intensities at 668 and
566 nm (F668/F566). As shown in previous studies [16], we also
find the extent of nPA oligomerization in the absence of co-
assembly factors is slight over the time course of one hour (Fig. 1B).
Consistent with previous studies [16], the presence of msANTXR2
does not stimulate PA assembly appreciably; rather it modestly
increases the extent of assembly when compared to the nPA
control. We fit the resulting FRET, F, vs time (t) data with a
second-order rate model [16]
Ft ðÞ ~A= 1zkt ðÞ zconstant ð1Þ
For msANTXR2 stimulated assembly, we estimate that the
observed rate constant, k, is 0.05 (60.03) s
21 with an amplitude, A,
of 20.15 (60.02). Both LFN and dsANTXR2 greatly stimulate the
extent of PA assembly, A values of 21.12 (60.02) and 21.29
(60.04), respectively (Fig. 1B), where the relative extent of
assembly over msANTXR2 stimulated assembly is increased ,7
and 9-fold, respectively. We find that, relative to msANTXR,
dsANTXR2, with a k of 0.19 (60.01) s
21, accelerates the rate of
oligomerization ,4-fold (Fig. 1B). Thus we conclude that
ANTXR2 dimerization stimulates both the rate and extent of
PA assembly.
Mass spectrometry analysis of PA7(LFN)3 and PA8(LFN)4
co-complexes with msANTXR2
Quantitative fluorescence [16] and X-ray crystallographic
studies [17] similarly report that PA7 binds 7 msANTXR2
domains. Using mass spectrometry (MS), we can also determine
the stoichiometry of anthrax toxin complexes. Previous studies
reported that nPA and LFN form PA-LFN complexes containing
PA7 and PA8 [21]. Here we find that when this mixture of PA-LFN
complexes is liganded by an excess of msANTXR2, two high-
molecular mass species of 677,125 (670) Da and 791,823 (6128)
are formed. These masses are consistent with the theoretical
molecular masses of the PA7(LFN)3(msANTXR2)7 and
PA8(LFN)4(msANTXR2)8 complexes, respectively (Fig. 2,
Table 1). (Note, for simplicity, we refer to these complexes as
PA7-msANTXR2 and PA8-msANTXR2, respectively.) Also
present at slightly lower relative abundances are the assembly
intermediates, PA2LFN(msANTXR2)2 and PA4(LFN)2(ms
ANTXR2)4 (Fig. 2). Finally, the free monomers, msANTXR,
PA20 and LFN, are observed in the range m/z 1000–3500 (Fig. 2).
Thus we conclude that the PA oligomer architecture does not
preclude the binding of a complete stoichiometric complement of
ANTXR domains.
EM analysis of the stability of PA7 and PA8 co-complexes
with msANTXR2
Using electron microscopy (EM), we measure the relative pH-
dependent stabilities of the two different PA oligomers. Here we
equate complex stability with the ability of the complex to remain
soluble. Prior studies show that insoluble toxin complexes are also
inactive [22]. To examine the stability of these complexes, we
briefly incubate the oligomeric mixture of PA-msANTXR2
complexes (78% PA7, 22% PA8) for 5 min at 37uC under a range
of pH conditions, and then we analyze the composition of the
resulting soluble complexes by EM (Fig. 3). At pH 8.0, we observe
Figure 2. Nanoelectrospray mass spectrometry analysis of PA-LFN-msANTXR2 oligomer complexes. Nanoelectrospray MS of sANTXR-
PA-LFN complexes (,2 mM) in 200 mM ammonium acetate, 2 mM ammonium bicarbonate, 0.2 mM magnesium acetate, pH 7.8. The y-axis is scaled
106in the range m/z 6000–13,000, and the x-axis is expanded in the range m/z 10,000–13,000 to aid viewing low relative abundance and closely
spaced peaks in these regions. See also Table 1 for the respective molecular mass values for each complex.
doi:10.1371/journal.pone.0013888.g002
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we largely observe indiscernible aggregates (Fig. 3A). We find that
the number of soluble PA-msANTXR2 prechannel co-complex
particles per micrograph decreases as a function of pH with a pH
midpoint of 5.8 (Fig. 3B, Table 2). The sharp decrease in the
average number of soluble prechannel co-complex particles per
micrograph also coincides with the appearance of large aggregates
(Fig. 3A). The appearance of the latter is indicative of premature
formation of the PA channel [22]. Data from a similar study of
ANTXR-free PA oligomer particles [22] show a different result,
where the pH-dependent transition was biphasic with two different
pH midpoints, corresponding to the PA7 and PA8 oligomers
(Fig. 3B) [22]. We conclude that when PA7 and PA8 complexes
bind to msANTXR2 they are stabilized similarly and their
solubility as a function of pH reveals a coincident sigmoidal pH
dependence.
We then asked if the monophasic sigmoidal transition in the
number of soluble PA-msANTXR2 prechannel co-complex
particles resulted from the two different PA oligomers having
identical pH dependencies for channel formation (and aggrega-
tion). To address this question, we measured the relative
proportions of the PA7-msANTXR2 and PA8-msANTXR2
complexes at each pH. From the negative-stain electron
micrographs taken at each pH value, we apply a reference-based
alignment, classification, and averaging analysis of all distinct
soluble particles (Fig. 3A, inset) [21]. This analysis, which
generates average images of the ring-shaped particles, shows that
the percentages of PA7 and PA8 are constant over the range of
pH 8 to 6 (Fig. 3B, Table 2). The constant percentages observed
for these msANTXR2-bound oligomer complexes are in stark
contrast to what is observed with msANTXR-free PA oligomer
complexes (Fig. 3B). Thus, when in complex with the msANTXR2
domain, PA7 and PA8 have identical pH dependent stabilities and
tend to aggregate with identical pH midpoints of 5.8.
Circular dichroism changes in PA7-msANTXR2 and
PA8-msANTXR2 complexes
Circular dichroism (CD) spectroscopy studies provide a
structural probe for PA’s transition from the prechannel state to
the channel state. This pH-dependent structural transition likely
explains the decrease in complex stability and solubility observed,
since PA channels tend to aggregate in solution [22]. The
secondary structure increases reported by CD signals have been
associated with channel formation because the pH-dependent CD-
signal change occurs at similar pH values as observed with other
probes for channel formation, including EM, MS, and SDS-PAGE
[22]. Using the CD signal at 222 nm (CD222nm), we can measure
the pH-dependent conformational changes in purified PA7-
msANTXR2 and PA8-msANTXR2 complexes (Fig. 4A, B). These
purified samples also contain full complements of LFN, but they
are highly enriched .90% in either the PA7 or PA8 oligomer [21].
Records of the pH-dependent CD222nm signal change of the PA
oligomer-msANTXR2 complexes at 37uC (Fig. 4A) show
equivalent results for either PA oligomer from pH 4.0 to 8.0
(Fig. 4B). The pH-dependent CD222nm signal changes for the PA7-
msANTXR2 and PA8-msANTXR2 complexes coincide, such that
the prechannel-to-channel transition midpoint is pH 5.8 (Fig. 4B).
Relative to the PA oligomers assayed under similar conditions in
the absence of msANTXR [22], this pH 5.8 midpoint is stabilized
by ,1.8 and ,1.2 pH units for the PA7 and PA8 oligomers,
respectively.
The pH-dependence of PA7-msANTXR2 channel
formation is temperature-independent
PA7 channel formation is both temperature-dependent as well
as pH-dependent [22,25]. However, while PA7 forms SDS-
resistant aggregates upon channel formation, PA8 apparently does
not [22]. We investigated the temperature-dependence of PA7-
msANTXR2 channel formation using the SDS-resistance assay
(Fig. 5). PA7-msANTXR2 complexes were incubated at 25uCo r
37uC for 1 hour at pH conditions from pH 8.0 to pH 5.0. Using
SDS-PAGE, we can monitor the formation of a low-mobility SDS-
resistant form, which is likely an aggregated form of the
heptameric PA channel [22]. In the absence of msANTXR2,
PA7 forms an SDS-resistant species at pH 7.4 and 7.0, at 25uC
and 37uC, respectively [22]. However, here we show, in the
presence of msANTXR2, that the SDS-resistant species first
appeared at pH 5.5 at 25uC and also at 37uC (Fig. 5). Therefore,
we conclude that the pH-dependence of PA7-msANTXR2
channel formation is temperature-independent.
Discussion
P Aa s s e m b l e so nc e l ls u r f a c e so nce it is proteolytically nicked
by a cell-surface furin-type protease [33] after the RKKR
sequence within a solvent accessible loop in domain 1 [20]. This
solvent accessible loop is also recognized by an unknown serum
protease found in various types of mammalian plasma [28]. The
resulting products of the cleavage by either type of protease are
the amino-terminal 20-kDa fragment, PA20,a n dt h ec a r b o x y -
terminal, 63-kDa fragment, PA63 [34]. The PA63 portion self-
assembles into either a heptameric [17,19,20,21] or octameric
[21] ring-shaped oligomer, whichcan maximally bind up to three
or four LF or EF molecules, respectively. Since assembly is
initially limited by this proteolytic activation step, then Atx
assembly can occur in two distinct environments, i.e., either (i) on
cell surfaces or (ii) free in solution in extracellular environments
such as plasma.
The cell-surface pathway is proposed to begin once secreted PA
monomers bind to cell-surface ANTXRs [13,14]. Furin-type
Table 1. Measured
a and theoretical
b molecular masses for msANTXR-PA-LFN complexes.
Sample Measured molecular mass
a (Da) Theoretical molecular mass
b (Da) Deviation (%)
msANTXR8(PA)8(LFN)4 791,823 (6128) 790,609 0.15
msANTXR7(PA)7(LFN)3 677,125 (670) 676,327 0.12
msANTXR4(PA)4(LFN)2 395,722 (633) 395,305 0.11
msANTXR2(PA)2LFN 197,815 (619) 197,652 0.08
aMolecular masses are measured using nanoelectrospray MS according to the method described in Kintzer et al. [21].
bTheoretical molecular masses are derived using the amino acid sequences of msANTXR, PA63, and LFN.
doi:10.1371/journal.pone.0013888.t001
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internalization to ensue. A complementary model has also been
proposed based on predominantly in vivo results; the model
suggests that PA monomers are proteolyzed in the host
bloodstream [28], assembling into toxin complexes prior to
reaching cell-surfaces [29]. We recently proposed that the
octameric toxin stably circulates in plasma, while the heptameric
toxin is unstable, forming aggregates of the prematurely formed
channel state [21,22]. Toxin aggregates have also been observed
in vivo, although their oligomeric composition is unknown [28].
While the cell-surface assembly model and plasma-based assembly
model are not mutually exclusive [21,22], future in vivo studies are
needed to distinguish the relative importance of the two assembly
pathways during anthrax infection. Here we provide evidence that
cell-surface assembly is likely driven by receptor dimerization;
however, unique from plasma-based assembly, the two different
Figure 3. EM analysis of the stability of PA7-msANTXR2 and PA8-msANTXR2 complexes from pH 8.0 to 5.0. (A) Representative
micrographs (49,0006) of PA-msANTXR2 complexes following a 5-minute exposure to 37uC at either pH 8.0 (left) or pH 5.0 (right). A 20-nm scale bar
is shown in white for either micrograph. (inset on left) Class-average images of PA7-msANTXR2 and PA8-msANTXR2 complexes; a 5-nm scale bar is
shown. (B) Quantitative analysis of the number of soluble PA oligomers and the relative proportions of PA7 and PA8, identified from electron
micrographs at each pH. (left) A plot of the average number of soluble prechannels versus pH for both free PA complexes (%, data taken from [22])
and msANTXR2-bound PA complexes (&) complexes. Error bars are propagated from the standard deviations of the mean number of particles
obtained from at least 10 micrographs for each pH. (right) A plot of the relative proportions of PA7 (black &) and PA8 (redN) complexes determined
using class-average image analysis for both PA-LFN (open symbols, data taken from [22]) and PA-LFN-msANTXR2 (filled symbols) complexes.
doi:10.1371/journal.pone.0013888.g003
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ANTXR2 interactions on cell surfaces.
ANTXR2 dimers stimulate PA oligomerization
The assembly of Atx on cell surfaces is not well understood. On
one hand, proteolysis, assembly, and internalization have been
shown to be rapid under physiological conditions, occurring within
minutes [35]. The mechanism of cell-surface assembly is not fully
understood in part because the structure of the full-length
ANTXR is unknown and in part because individual assembly
intermediates have not been isolated from cells. It is known,
however, that while the soluble extracellular domain of ANTXR2
is monomeric, as evidenced in crystallographic [15,17] and mass
spectrometry studies (Fig. 2), the full-length ANTXR2 is thought
to dimerize via its transmembrane single-pass helix domain, as
demonstrated in studies of the transmembrane domain in a
liposomal system [36]. Since ANTXR2 dimerization enhances the
formation of PA8, it was proposed that it may also facilitate
assembly at the cell-surface by populating dimeric intermediates,
because PA8 complexes are produced in that environment [21]. In
further support of this hypothesis, we also find evidence for even-
numbered receptor-bound dimeric and tetrameric species,
Table 2. Negative-stain
a EM analysis PA-msANTXR2 co-complexes following an exposure at 37uC
b.
pH Mean number of particles per micrograph
c Oligomeric compositiond
PA8 (%) PA7 (%) Total particles (N)
8.0 18 (64) 23 77 364
7.4 20 (67) 26 74 381
7.0 28 (68) 17 83 494
6.5 26 (66) 22 78 482
6.0 19 (64) 16 84 857
5.5 2 (61) n.d.
e n.d. n.d.
5.0 1 (61) n.d. n.d. n.d.
aNegative-stain electron micrographs using uranyl acetate stain, 2%.
bA pre-assembled population of PA-msANTXR2 complexes (containing 78% PA7 and 22% PA8) was incubated for 5 minutes at 37uC at the specified pH.
cThe mean number of particles per micrograph (n of 10 micrographs) given as 6s.d.
dOligomeric composition is determined using crystal-structure-referenced alignment and classification analysis [21,22]. The percentage reported is computed from the
total number of particles, N, comprising all PA7 and PA8 classes, where oligomeric composition is equal to the total number of PA7 or PA8 particles divided by N.
en.d., not determined. Class-average image analyses of these pH conditions are not shown due to the low particle counts observed. The low particle counts are
attributed to severe aggregation (as shown in Fig. 3A).
doi:10.1371/journal.pone.0013888.t002
Figure 4. The pH dependence of CD-signal changes for PA7- and PA8-msANTXR2 complexes. (A) Time-course records of the CD signal at
222 nm (CD222) for either an acid pulse (pH 5.0 final, red trace) or a control with no pH pulse (pH 8.0 final, black trace). (B) The pH-dependence of the
CD222-signal change for PA7(LFN)3 (black %, data taken from [22]), PA8(LFN)4 (red #, data taken from [22]), PA7(LFN)3(msANTXR2)7 (black &),
PA8(LFN)3(msANTXR2)8 (redN) complexes. Traces were normalized to the initial and final CD222 signals obtained.
doi:10.1371/journal.pone.0013888.g004
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mass spectra (Fig. 2). We conclude that the cell-surface assembly
mechanism likely occurs through dimeric PA intermediates, which
are stabilized via dimeric ANTXR complexes; and this mechanism
is akin to a putative extracellular plasma-based assembly
mechanism, whereby either EF or LF stabilizes dimeric PA
intermediates that can serve to drive assembly [21].
Previous studies have shown that the rate of PA assembly is
accelerated in the presence of LFN [16], which is believed to
bridge a binding site spanning the surface of a PA dimer [37]. In
this report, we consider the role of a dimeric receptor on the
kinetics of PA assembly. Our kinetic FRET measurements show
that dsANTXR2 stimulates PA assembly (Fig. 1B). Furthermore,
PA assembles ,6-fold faster with dsANTXR2 (relative to what is
observed when assembling with LFN.) This acceleration of the
assembly kinetics may reflect that PA binds ANTXR2 with a
higher affinity than LFN (170 pM versus 1 nM, respectively)
[16,38]. Therefore, we propose that ANTXRs, LF, and EF can
stimulate PA oligomerization by populating dimeric PA interme-
diates, which are precursor intermediates in the PA oligomeriza-
tion mechanism.
Stabilization of PA complexes by ANTXR2
The ANTXR-dependent stabilization of PA oligomers has been
demonstrated on cell-surfaces and in solution [17,19,25]. The
mechanism of receptor-mediated stabilization of PA complexes
occurs by reducing the pH threshold for PA channel formation by
,2 pH units. ANTXR2 prevents channel formation by forming a
metal-ion dependent structural bridge that spans domains 2 and 4,
restricting the conformational changes necessary for channel
formation [15,17]. While PA7 complexes have been shown to be
stabilized by ANTXR2 interactions [17], the relative stabilities of
PA7ANTXR27 and PA8ANTXR28 complexes has not been
reported. In the absence of msANTXR2, it has been demonstrat-
ed that PA7 and PA8 form channels at different pH values [22].
Our EM measurements of pH-dependent PA oligomer aggrega-
tion suggest that PA7- and PA8-msANTXR2 complexes instead
form channels at equivalent pH values with a pH midpoint of 5.8
(Fig. 3B). Our CD measurements also suggest that PA7- and PA8-
msANTXR2 complexes form channels at a pH midpoint of 5.8
(Fig. 4). Further evidence of this conclusion is provided by our
analysis of the percentages of soluble PA7 and PA8 oligomer
complexes over the tested pH range. From pH 8.0 to 6.0, we find
the relative ratio of PA7 and PA8 complexes is unaltered,
indicating that both PA7 and PA8 prechannels are stabilized by
msANTXR2 (Fig. 3B). These results are consistent with studies of
PA oligomerization on cell surfaces, revealing that the inherently
less stable PA7 complex is favored 2:1 over the PA8 complex [21].
Therefore, we infer that PA7 and PA8 are likely to form similar
structural interactions with ANTXR2, since both oligomers are
equally stabilized. We conclude that PA7- and PA8-msANTXR2
complexes form channels with identical pH dependencies and
possess equivalent stability when bound to ANTXR2 on cell
surfaces.
Role of ANTXR2 stabilization during pathogenesis
In plasma, LT complexes containing PA8 oligomers are
inherently more stable than those containing PA7 oligomers, thus
allowing the LT containing PA8 complexes to persist for longer
periods of time in that environment [22]. This stabilization
mechanism defines an important role for PA8 oligomers in anthrax
pathogenesis. However, as we report here, toxin complexes
containing either PA7 or PA8 oligomers are equally stabilized by
interactions with ANTXR2 (Fig. 6), and thus the 70:30 ratio of
heptamers to octamers observed on cell surfaces [21] can be fully
explained by the receptor-mediated stabilization data presented
here (Fig. 3B). Therefore, Atx assembly may be a means to regulate
toxin activity and generate toxin gradients in the host (Fig. 7). We
expect that, due to its relatively short half life, PA7 activity may
effectively localize near to sites of infection [22], whereas PA8 may
circulate systemically and provide a longer-range source of toxin
activity. The stabilization imparted upon binding to the ANTXR
allows for PA7 containing toxin complexes to be more concentrated
and efficacious at sites proximal to the site of infection. The levels of
available free LF may control the levelsof PA8 complexes produced.
This mechanism should provide a means to maintain higher levels
of toxin activity near to the sites of infection while preventing
premature system-wide shock until PA8 complexes are produced on
a larger scale. As the infection progresses and a fever in the host
develops, PA8 complexes may be required because they are more
thermostable and remain active even after extended exposure to
elevatedtemperatures[22].Futureworkshouldinvestigatethetypes
ofAtxcomplexesproducedthroughoutthevariousstagesofanthrax
pathogenesis.
Materials and Methods
Proteins
Recombinant wild-type PA83 [39] was over-expressed in the
periplasm of the Escherichia coli strain, BL21(DE3). The 83-kDa PA
monomer was purified from the periplasm as described [16].
Recombinant LFN (LF residues 1-263) was overexpressed in
BL21(DE3) via a pET15b construct [40] and then purified from
the cytosol as described [16]. Soluble human anthrax receptor
domain, msANTXR2, from the capillary morphogenesis protein 2
(residues 40–217) [14] was expressed and purified as described
[15]. The six-histidine affinity tags were removed from
msANTXR2 and LFN by treatment with bovine a-thrombin. A
soluble, dimeric fusion of human anthrax receptor domain to
glutathione S-transferase (GST), dsANTXR2, was also expressed
and purified as described [21].
Preparation of purified PA7-msANTXR2 and
PA8-msANTXR2 co-complexes
PA7(LFN)3 was produced using Q-sepharose-purified PA oligo-
mers [21] by forming complexes with a two-fold stoichiometric
excessofLFN(LFN:PA)and purifiedasdescribed[22].Theresulting
complexes contained .90% PA7.P A 8(LFN)4 was prepared by
Figure 5. The formation of SDS-resistant PA7(LFN)3(m-
sANTXR2)7 complexes is temperature-independent. SDS-resis-
tance assays [25] were performed with PA7(LFN)3(msANTXR2)7 com-
plexes, which were incubated at the indicated pH at either 25uCo r
37uC. The two species of interest on the SDS-PAGE gels are indicated as
either the high-molecular-weight, SDS-resistant PA oligomer band (*) or
low-molecular-weight SDS-soluble, PA63 monomer band (PA63).
doi:10.1371/journal.pone.0013888.g005
Receptor Drives Toxin Assembly
PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e13888assembling nPA in the presence of LFN (nPA-LFN, a mixture that
contains ,20–30% PA8), following incubation and purification by
gel filtration as described [21,22]. PA-msANTXR2 complexes were
formed by mixing 1 mMP A 7(LFN)3 or PA8(LFN)4 with ten molar
equivalents of purified msANTXR2 (10 mM) in Buffer E (20 mM
Tris, 150 mM NaCl, pH 8) plus 1 mM MgCl2. The complex was
formed at room temperature over the course of 15 minutes.
PA83 labeling with fluorescent dyes
AP A 83 mutant K563C was expressed and purified in the
presence of 5 mM DTT. Prior to the reaction, the DTT was
removed by buffer exchange on a G25 desalting column (GE
Healthcare, USA), equilibrated in nitrogen-purged Buffer E.
Labeling reactions were initiated by mixing DTT-free PA83
K563C with 10 molar equivalents of Alexa fluor 555 C5
maleimide (AF555) or Alexa fluor 647 C5 maleimide (AF647)
(Invitrogen, USA) in the presence of 100 mM tris(2-carboxyethyl)-
phosphine (TCEP, Sigma Aldrich, USA) and incubated at room
temperature for 3 hours. The reaction was quenched with 5 mM
DTT and purified on a G25 desalting column to remove free,
unreacted dye molecules. Labeling efficiency was determined by
comparing dye and protein absorbance values. Labeling efficien-
cies of .90% were achieved for either dye.
Figure 6. A model for anthrax toxin assembly. A model for anthrax toxin assembly in plasma and at cells surfaces. (A) In principle, PA
components may assemble into a 70:30 PA7:PA8 mixture of toxin complexes in plasma. However, PA7 readily converts to the channel state and
aggregates within 5 minutes under these conditions, leaving PA8 as the predominant soluble toxin complex capable of infecting cells [22]. By
contrast, both oligomeric forms are equally stable at the cell surface, where binding to ANTXR2 serves to prevent premature channel formation until
PA7 or PA8 complexes are properly internalized and the endosomal compartment is acidified to pH values ,6. On cell surfaces, PA may also
oligomerize into a 70:30 PA7:PA8 mixture [21], where assembly is driven through interactions with dimeric ANTXR complexes. These complexes are
then able to bind LF and become internalized into cells.
doi:10.1371/journal.pone.0013888.g006
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Dye-labeled, nicked PA (nPA K563C*AF555 or nPA
K563C*AF647) was prepared as described previously [41]. To
initiate assembly, nPA K563C*AF555 and nPA K563C*AF647 were
each diluted to 50 nM in 10 mM sodium cacodylate, 100 mM
potassium chloride, 1 mM magnesium chloride, pH 7.4 either in
the presence or absence of 100 nM LFN, 100 nM msANTXR2, or
100 nM dsANTXR2. Assembly was observed as an increase in the
emission intensity ratio at 668 and 566 (62) nm (F668/F566) upon
excitation at 555 (65) nm, which reached a steady state in about
one hour. Emission values were obtained every five minutes on a
Horiba Jobin Yvon FluoroMax-3 spectrofluorometer, using quartz
cuvettes with a 1-cm path length.
Mass Spectrometry
Mass spectra of the protein complexes were acquired using a
quadrupole time-of-flight (Q-TOF) mass spectrometer equipped
with a Z-spray ion source (Q-TOF Premier, Waters, Milford,
MA). Ions were formed using a nanoelectrospray (nano-ESI)
emitter prepared by pulling borosilicate capillaries (1.0 mm O.D./
0.78 mm I.D., Sutter Instruments, Novato CA) to a tip I.D. of
,1 mm with a Flaming/Brown micropipette puller (Model P-87,
Sutter). The instrument was calibrated with CsI clusters formed by
nano-ESI using a 20 mg/mL solution of CsI in 70:30 Milli-Q
water:2-propanol prior to mass measurement. The protein
solution was concentrated to ,10 mm followed by dialysis into
10 mM ammonium bicarbonate, 1 mM magnesium acetate,
pH 7.8. Immediately prior to mass analysis, the solution was
diluted 1:4 with 200 mM ammonium acetate, pH 7.8. A platinum
wire (0.127 mm diameter, Sigma, St. Louis, MO) was inserted
through the capillary into the solution and electrospray was
initiated and maintained by applying 1–1.3 kV to the wire (relative
to instrument ground). Each raw dataset was smoothed three times
using the Waters MassLyn software mean smoothing algorithm
with a window of 25 m/z (mass-charge ratio).
Electron microscopy
PA-msANTXR2 complexes were prepared in Buffer E plus
1 mM MgCl2 as described above, applied to a freshly glow-
discharged 400 mesh formvar-carbon coated grids, and stained
with 2% uranyl acetate (Sigma-Aldrich, St. Louis, MO) as
described [21,22]. Negative-stain EM images were recorded on
a Tecnai 12 electron microscope (FEI Company, Hillsboro, OR)
operated at 120 kV at a magnification of 49,0006using a CCD
camera. The micrograph resolution was 2.13 A ˚/pixel. Particle
images were selected using manual particle picking using boxer in
EMAN [42]. Boxed images of the PA oligomer particles were
subjected to successive cycles of reference-free and reference-based
alignment, multivariate statistical analysis, and classification using
SPIDER [43,44,45], as described [21,22]. Final class-average
images were manually inspected to determine their oligomeric
state and tabulated to determine the oligomeric composition of
each sample (Table 2).
Circular dichroism (CD) spectroscopy
CD measurements of the PA channel transition were obtained
on a JASCO Model 810 spectropolarimeter (JASCO, Inc., Easton,
MD). To determine the pH-dependence of the prechannel-to-
channel transition, PA-msANTXR2 co-complexes were diluted to
50 nM in 2 mL of the buffer: 10 mM potassium phosphate,
10 mM potassium acetate, 0.1 M potassium chloride, 1 mM
magnesium chloride, pH 8. The CD measurement was made
using a 161-cm quartz cuvette containing a Teflon stir bar, at
25uCo r3 7 uC. Recordings of the CD222nm signal were conducted
at a 1-Hz sampling rate. During the recording the pH of the
sample was reduced by adding 0.4 M phosphoric acid to obtain
the desired pH, as described [22]. The CD222nm transition was
then observed and recorded for an additional 60 s. The final pH of
the sample in the cuvette was determined using a pH meter.
SDS-resistance PAGE analysis
SDS-resistance assays [25] were performed with purified PA7-
msANTXR2 complexes. The purified PA7(LFN)3 samples were
complexed with msANTXR2 as described above, forming PA7-
msANTXR2. PA7-msANTXR2 complexes were diluted to 1 mg/
ml final concentration (with respect to PA) in Buffer E plus 1 mM
MgCl2. The following buffers were added to preformed complex-
es, which vary depending upon the pH: 0.1 M Tris-Cl (pH 8.0),
sodium cacodylate (pH 6.5 to 7.5), 0.1 M 2-(N-morpholino)etha-
nesulfonic acid (pH 6.0), and sodium acetate (pH 5.0 to 5.5). The
complexes were incubated for 1 hour at 25uCo r3 7 uC. 1.25%
SDS then was added, and the samples were run on a 12%
polyacrylamide gel, which was stained in Coomassie Brilliant Blue
G-250.
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Figure 7. A model for the regulation of toxin activity in plasma.
The assembly of LT complexes with different lifetimes may serve as a
means to regulate toxin activity in plasma during infection. The reduced
lifetime of PA7 complexes in plasma may limit their cytotoxic effects to
local areas in close proximity to the site of B. anthracis infection. By
contrast, PA8, which is produced at lower levels, has a longer lifetime,
thereby allowing it to exert cytotoxic effects over longer distances.
doi:10.1371/journal.pone.0013888.g007
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